Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1

3(60.0%)

Phase 3

1(20.0%)

Early Phase 1

1(20.0%)

5Total

Phase 1(3)

Phase 3(1)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06942039Early Phase 1Recruiting

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

Role: lead

NCT06208657Phase 1Recruiting

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

Role: collaborator

NCT02303028Phase 1Completed

Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid Tumours

Role: collaborator

NCT02175615Completed

Pharmacological Predictors of Successful Cyclosporine Acute GVHD Prophylaxis in Children Undergoing HSCT

Role: collaborator

NCT01913093Completed

N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors

Role: collaborator

NCT01805778Completed

Preventing Cardiac Sequelae in Pediatric Cancer Survivors

Role: collaborator

NCT01858155Phase 1Completed

Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors

Role: lead

NCT01135550Phase 3Terminated

Low Dose Versus Usual Dose Dexamethasone for Symptom Control in Children Undergoing Cranial or Craniospinal Radiation

Role: collaborator

NCT01104324Unknown

Osteonecrosis in Children With Acute Lymphoblastic Leukemia

Role: collaborator

All 9 trials loaded